Adani Global Acquires Stake in ForSight Robotics, Advancing Ophthalmic Surgery

The cost of the acquisition is USD 20 million and the Adani Group said that it is "in furtherance of the strategic objectives of the Adani Enterprises Limited to undertake investments which provide synergistic benefits to the existing businesses of the company."

Adani Global Acquires Stake in ForSight Robotics, Advancing Ophthalmic Surgery
Adani Global Acquires Stake in ForSight Robotics, Advancing Ophthalmic Surgery

Adani Group Invests $20 Million in ForSight Robotics to Transform Ophthalmic Surgery

In a significant move, Adani Global Limited – Mauritius has completed the acquisition of a minority stake in ForSight Robotics, a startup dedicated to revolutionizing ophthalmic surgery through innovative robotics.

ForSight’s Vision for the Future: Robotic Ophthalmic Surgery for All

ForSight Robotics is on a mission to redefine the landscape of medical procedures with their pioneering robotic surgery platform, focusing on treating a wide range of conditions, including Cataract, Glaucoma, and retinal diseases.

Adani Group’s Synergistic Investment to Propel Ophthalmic Precision Worldwide

This strategic investment aligns with Adani Group’s vision and enhances the synergy with its existing businesses, paving the way for high-precision, cost-effective, and vision-saving ophthalmic surgery.

In this groundbreaking collaboration, Adani Group, a multinational conglomerate, is set to propel ForSight Robotics to new heights in the world of ophthalmic surgery. Dr. Glozman, Co-Founder and CEO of ForSight, expressed his delight in the partnership, highlighting the potential to transform ophthalmic surgery.

“Adani Group’s investment will help us deliver ophthalmic surgery that is high-precision, cost-effective, and vision-saving,” Dr. Glozman stated.

ForSight Robotics is not just focused on precision but also accessibility. Dr. Nathan, Co-Founder and Chief Business Officer, emphasized the global reach of their robotic ophthalmic platform. “Our robotic ophthalmic platform will enable patients to receive treatment anywhere in the world to help them regain sight,” Dr. Nathan explained.

The startup’s vision extends beyond surgical precision. It aims to empower ophthalmic surgeons to perform procedures remotely, opening up new possibilities for patient treatment and care. Adani Group’s strategic investment marks a significant milestone in advancing the future of ophthalmic surgery.

Also Read: “Cancer in Families: Understanding the Impact of Family History”

Facebook Comments